Global Breast Cancer Drug Pipeline Capsule - 2012

Fore Pharma, February 2012, Pages: 17

‘Global Breast Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global Breast Cancer drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the Breast Cancer drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report:

- Breast Cancer: Overview
- Breast Cancer Drug Pipeline Overview
- Breast Cancer Phase 3 Clinical Trial Drug Pipeline Insights
- Breast Cancer Phase 2 Clinical Trial Drug Pipeline Insights
- Breast Cancer Phase 1 Clinical Trial Drug Pipeline Insights
- Breast Cancer Preclinical Research Drug Pipeline Insights
- Breast Cancer Drug Discovery Pipeline Insights
- Geographic Landscape of Breast Cancer R&D Activities
- Breast Cancer R&D Activities in North America
- Breast Cancer R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Breast Cancer Drug Market

1. Breast Cancer: Disease Definition
2. Breast Cancer Drug Pipeline Overview
3. Breast Cancer Phase 3 Clinical Trial Drug Pipeline Insights
4. Breast Cancer Phase 2 Clinical Trial Drug Pipeline Insights
5. Breast Cancer Phase 1 Clinical Trial Drug Pipeline Insights
6. Breast Cancer Preclinical Research Drug Pipeline Insights
7. Breast Cancer Drug Discovery Pipeline Insights
8. Geographic Landscape of Breast Cancer R&D Activities
8.1. Breast Cancer R&D Activities in North America
8.2. Breast Cancer R&D Activities in Europe
9. Licensing Activities / Partnerships in the Global Breast Cancer Drug Market
10. Research Methodology

List of Tables

Table 1: Breast Cancer Drug Pipeline: Phase 3 Clinical Trial Molecules
Table 2: Breast Cancer Drug Pipeline: Phase 2 Clinical Trial Molecules
Table 3: Breast Cancer Drug Pipeline: Phase 1 Clinical Trial Molecules
Table 4: Breast Cancer Drug Pipeline: Preclinical Research Molecules
Table 5: Breast Cancer R&D Activities by Geography
Table 6: Breast Cancer Drug Pipeline: North America
Table 7: Breast Cancer Drug Pipeline: Europe
Table 8: Breast Cancer Drug Pipeline: Licensing Activities

List of Figures

Figure 1 : Breast Cancer Drug Pipeline Molecules by Stages
Figure 2 : Breast Cancer R&D Activities by Geography

Customers who bought this item also bought

• Global Breast Cancer Drug Pipeline Capsule - 2012 Update
• Global Oncology Drug Pipeline Capsule – 2012
• Global Breast Cancer Epidemiology and Patient Flow Analysis - 2012
• Global Ovarian Cancer Drug Pipeline Capsule - 2012 Update
• Global Pancreatic Cancer Drug Pipeline Capsule - 2012 Update
• Global Renal Cancer Drug Pipeline Capsule - 2012 Update
• Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update
• Global Bladder Cancer Drug Pipeline Capsule - 2012 Update
• Global Brain Cancer Drug Pipeline Capsule - 2012 Update
• Global Cervical Cancer Drug Pipeline Capsule - 2012 Update